1. Antivascular Therapy for Epithelial Ovarian Cancer. (17th November 2009) Authors: Duhoux, Francois P.; Machiels, Jean-Pascal Other Names: Markman Maurie M. Academic Editor. Journal: Journal of oncology Issue: Volume 2010(2010) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of Perioperative Hypnosedation on Postmastectomy Chronic Pain: Preliminary Results. (August 2019) Authors: Lacroix, Camille; Duhoux, Francois P.; Bettendorff, Julie; Watremez, Christine; Roelants, Fabienne; Docquier, Marie-Agnes; Potié, Arnaud; Coyette, Maude; Gerday, Amandine; Samartzi, Vasiliki; Piette, Philippe; Piette, Nathan; Berliere, Martine Journal: Integrative cancer therapies Issue: Volume 18(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Routine use of gene panel testing in hereditary breast cancer should be performed with caution. (December 2016) Authors: van Marcke, Cedric; De Leener, Anne; Berlière, Martine; Vikkula, Miikka; Duhoux, Francois P. Journal: Critical reviews in oncology/hematology Issue: Volume 108(2016) Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant. (March 2022) Authors: Malorni, Luca; Tyekucheva, Svitlana; Hilbers, Florentine S.; Ignatiadis, Michail; Neven, Patrick; Colleoni, Marco; Henry, Stéphanie; Ballestrero, Alberto; Bonetti, Andrea; Jerusalem, Guy; Papadimitriou, Konstantinos; Bernardo, Antonio; Seles, Elena; Duhoux, Francois P.; MacPherson, Iain R.; Thoms... Journal: European journal of cancer Issue: Volume 164(2022) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Survival outcomes after neoadjuvant letrozole and palbociclib versus third generation chemotherapy for patients with high-risk oestrogen receptor-positive HER2-negative breast cancer. (May 2022) Authors: Delaloge, Suzette; Dureau, Sylvain; D'Hondt, Véronique; Desmoulins, Isabelle; Heudel, Pierre-Etienne; Duhoux, Francois P.; Levy, Christelle; Lerebours, Florence; Mouret-Reynier, Marie A.; Dalenc, Florence; Frenel, Jean-Sébastien; Jouannaud, Christelle; Venat-Bouvet, Laurence; Nguyen, Suzanne; Cal... Journal: European journal of cancer Issue: Volume 166(2022) Page Start: 300 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. UCBG 2-08: 5-year efficacy results from the UNICANCER-PACS08 randomised phase III trial of adjuvant treatment with FEC100 and then either docetaxel or ixabepilone in patients with early-stage, poor prognosis breast cancer. (November 2018) Authors: Campone, Mario; Lacroix-Triki, Magali; Roca, Lise; Spielmann, Marc; Wildiers, Hans; Cottu, Paul; Kerbrat, Pierre; Levy, Christelle; Desmoulins, Isabelle; Bachelot, Thomas; Winston, Tan; Eymard, Jean-Christophe; Uwer, Lionel; Duhoux, Francois P.; Verhoeven, Didier; Jaubert, Dominique; Coeffic, Dav... Journal: European journal of cancer Issue: Volume 103(2018) Page Start: 184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗